Izuru Ando
Impact in
- Hepatology top 5%
- Hepatitis C virus research
- Organic Chemistry top 10%
- Synthesis and biological activity
- Synthesis and Biological Evaluation
- Multicomponent Synthesis of Heterocycles
- Catalytic C–H Functionalization Methods
Papers in
-
- Hepatitis C virus research 8
-
- Hepatitis B Virus Studies 5
- Liver Disease Diagnosis and Treatment 2
- Co-authors
- Satoru Ikeda (5 shared papers)Shintaro Hirashima (4 shared papers)Hiromasa Hashimoto (4 shared papers)Takayoshi Suzuki (2 shared papers)Satoru Noji (3 shared papers)Tsuyoshi Adachi (3 shared papers)Kazuo Nagai (1 shared paper)Takao Kataoka (1 shared paper)
- Journals
- Bioorganic & Medicinal Chemistry Letters (2 papers)Journal of Medicinal Chemistry (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)Virology (1 paper)International Immunopharmacology (1 paper)
- Partner nations
- JapanUnited States
In The Last Decade
Izuru Ando
9 papers receiving 472 citations
Peers
Comparison fields: 5 of 64
- Hepatology 159
- Organic Chemistry 197
- Infectious Diseases 105
- Toxicology 11
- Pharmacology 28
Countries citing papers authored by Izuru Ando
This map shows the geographic impact of Izuru Ando's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Izuru Ando with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Izuru Ando more than expected).
Fields of papers citing papers by Izuru Ando
This network shows the impact of papers produced by Izuru Ando. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Izuru Ando. The network helps show where Izuru Ando may publish in the future.
Co-authors
The 25 scholars most cited alongside Izuru Ando, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 124 | |
| 2 | 2002 | 115 | |
| 3 | 2006 | 109 | |
| 4 | 2006 | 85 | |
| 5 | 2007 | 30 | |
| 6 | 2012 | 12 | |
| 7 | 2008 | 8 | |
| 8 | 2012 | 1 | |
| 9 | 2013 | 1 |
About Izuru Ando
Izuru Ando is a scholar working on Hepatology, Epidemiology, Infectious Diseases, Organic Chemistry and Small Animals, having authored 9 papers that have together received 485 indexed citations. Recurring topics across this work include Hepatitis C virus research (8 papers), Hepatitis B Virus Studies (5 papers), HIV/AIDS drug development and treatment (4 papers), Quinazolinone synthesis and applications (2 papers), Liver Disease Diagnosis and Treatment (2 papers), interferon and immune responses (1 paper), Systemic Lupus Erythematosus Research (1 paper) and Essential Oils and Antimicrobial Activity (1 paper). The work is most often cited by research in Hepatology (159 citations), Organic Chemistry (197 citations), Infectious Diseases (105 citations), Toxicology (11 citations) and Pharmacology (28 citations). Izuru Ando has collaborated with scholars based in Japan and United States. Frequent co-authors include Satoru Ikeda, Shintaro Hirashima, Hiromasa Hashimoto, Takayoshi Suzuki, Satoru Noji, Tsuyoshi Adachi, Kazuo Nagai, Takao Kataoka, Kensuke Miyake and Yoshinori Tsukumo. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy, Virology and International Immunopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.